Novartis | NOVN - Interest Income

Stock Price
114.72
Daily Change
0.64 0.56%
Monthly
-4.26%
Yearly
21.77%
Q2 Forecast
111.47

Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Almirall EUR 2.71M 580K Dec/2025
AstraZeneca USD 85M 17M Sep/2025
Autolus Therapeutics Ltd USD 6.14M 1.31M Mar/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Fresenius Medical Care EUR 13.62M 5.54M Dec/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
J&J USD 2.14 237M Mar/2026
Merck EUR 27M 10M Sep/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Philips EUR 21M 2M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 33M 81M Dec/2025